Adrenal& Bone Complications in Paediatric Patients Living With Spinal Muscular Atrophy (SMA)
This study aims to understand bone problems, like weak bones and fractures, in children and teenagers with Spinal Muscular Atrophy (SMA) in the UK. We know new SMA treatments are helping patients live longer and move better, but some are still experiencing bone issues. We're not sure if these bone problems are due to less movement, the SMA itself, or even some treatments. This research will look at existing medical information, like how often fractures occur and how different SMA treatments might play a role, including steroid use. The goal is to figure out the best ways to monitor bone health in SMA patients, ultimately helping to improve their care. We will only be reviewing existing medical records, so no new tests will be carried out.
At a glance
What is this study about?
Spinal Muscular Atrophy (SMA) is a condition that affects special nerve cells in your spinal cord that control movement. These nerve cells, called motor neurons, send signals from your brain to your muscles. When these nerves don't work properly, muscles can become weak and waste away, making it hard to move, breathe, and swallow. In recent years, new medicines have become available that can really help people with SMA live longer and move more easily.
While these new treatments are fantastic, doctors have noticed that some children and teenagers with SMA are still having other health problems, particularly with their bones. They've seen patients getting fractures (broken bones) more easily and having weaker bones from a young age. We don't yet know if this is because SMA can make it harder for children to move around, which then affects their bone strength, or if the SMA itself directly impacts bone health. We also want to find out if the new SMA medicines help improve bone health, or if certain treatments, like high doses of steroids sometimes used with one SMA drug, might actually make bones weaker.
This study will carefully look at information already collected from children and teenagers with SMA across the UK. We'll be reviewing existing medical records to understand how common bone problems are, what types of fractures happen, and how bone health compares between patients receiving different SMA treatments or no treatment at all. We also want to understand the effect of steroid use on bones. The main goal is to figure out the best ways to check and record bone health in SMA patients, so doctors can provide the best possible care for their bones. Importantly, if your child's information is included, no new tests or procedures will be done; we will only be reviewing existing data.
Key takeaways
- The study focuses on bone health in children and teenagers with SMA.
- It aims to understand why weak bones and fractures occur and if treatments affect them.
- No new tests or clinic visits are required for participants.
- Researchers will only review existing medical records and data.
- The findings could help improve future bone care for SMA patients.
Who may be eligible?
To be included in this study, participants must already be part of the UK's national SMA REACH UK database for children. This database collects important information about young people with SMA.
We are looking at data for children under 16 years old as of May 1, 2025. If a participant was on the SMA REACH UK database as a child but is now over 16, their information can still be included, but only if they have given their updated consent to SMA REACH UK after their 16th birthday.
If a participant from the database is over 16 years old and has not given new consent after turning 16, then any information collected after their 16th birthday will not be used in this study.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Is my child already part of the national SMA REACH UK database?
- Is my child under 16 years old (as of May 1, 2025)?
- If my child is over 16, have they re-consented to the SMA REACH UK database since turning 16?
- My child does not have any health conditions that would exclude them from a medical records review.
What does participation involve?
Taking part in this study simply means that researchers will look at your child's existing medical records and information that has already been collected as part of the SMA REACH UK national database. There will be no extra hospital visits, no new medical tests, and no additional medications for your child. Your daily routine will not change at all. The researchers will be reviewing anonymised data, meaning your child's name and personal details will be removed to protect their privacy.
Potential risks and benefits
Locations (1)
- Sheffield Children's NHS Foundation TrustVerified postcodeSheffield, United Kingdom
Common questions
What is Spinal Muscular Atrophy (SMA)?
SMA is a genetic condition that affects nerve cells controlling muscle movement, leading to muscle weakness and wasting.
Why are you studying bones in SMA patients?
We've noticed that many SMA patients experience problems like weak bones and fractures, and we want to understand why this happens and if treatments play a role.
Will my child need to have any extra tests?
No, this study only involves looking at existing medical records and data already collected. Your child will not need any new tests or appointments.
Who is running this study?
This study is being led by researchers who are part of the SMA REACH UK network, a group focused on improving care for people with SMA.
How will my child's privacy be protected?
All personal details will be removed from the medical records and data before it is analysed, so your child's information will be kept private.
How to find out more
Gillian Gatenby
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.